Megatas 50mg 10 Tablets

Babies: Nil. Lactating mother: Consult your doctor before using this medication as it is unsafe in lactating mothers. Limited human studies show that the drug may pass into breast milk and cause harm to the baby. Pregnancy: Consult your doctor before using this medication as it is unsafe during pregnancy.
There is limited human and animal studies show that shows the harmful effects on the baby. Alcohol: This medication is used with caution with alcohol consumption. Driving: This medication may not affect your ability to drive. Kidney: This medicine should be used with caution in patients with kidney disease. Dose adjustment is required.
Consult your doctor before taking this medicine. Liver: This medicine should be used with caution in patients with liver diseases.
Dose adjustment is required in these patients. Consult your doctor before using this medicine.
This medicine is not recommended in patients with severe liver disease..

Hypertension Tachycardia Constipation Dry mouth Headache Urinary tract infectious disease Nasopharyngitis Cerebrovascular accident Urinary retention Cancer.

Megatas tablet is a urinary enuresis agent used to relieve the symptoms of overactive bladder such as increased or frequent urination, urgent need to urinate and inability to control urination; it works by relaxing the smooth muscle bladder and strengthen its ability to store urine..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Megatas tablet is prescribed to treat symptoms of overactive bladder. • Always monitor your blood pressure as the drug may cause alteration. • Take the medication with food. • It may cause side effects such as hypertension, tachycardia, constipation, dry mouth, headache, urinary tract infection, nasopharyngitis, urinary retention. Inform your doctor if these effects bother or worsen your condition. • This medicine may also cause less drowsiness and constipation than other medicines used for overactive bladder..

• Megatas + Eliglustat: Concurrent use of these medications may result in increased eliglustat exposure and subsequent prolongation of the qt interval. • Megatas + Thioridazine: Concurrent use of these medications may result in increased thioridazine exposure. • Megatas + Clozapine: Concurrent use of these medications may result in increased clozapine exposure. • Megatas + Codeine/dihydrocodeine: Concurrent use of these medications may increase codeine plasma concentrations and reduced plasma concentrations of the active metabolite. • Megatas + Propafenone: Concurrent use of these medications may result in increased propafenone exposure. • Megatas + Sirolimus: Concurrent use of these medications may result in increased exposure to sirolimus. • Megatas + Tramadol: Concurrent use of these medications may result in increased tramadol exposure and reduced concentrations of the active metabolite. • Megatas + Amitriptyline: Concurrent use of these medications may result in increased amitriptyline exposure. • Megatas + Clomipramine: Concurrent use of these medications may result in increased clomipramine exposure. • Megatas + Desipramine: Concurrent use of these medications may result in increased desipramine exposure. • Megatas + Digoxin: Concurrent use of these medications may result in increased digoxin exposure. • Megatas + Duloxetine: Concurrent use of these medications may result in increased duloxetine exposure. • Megatas + Ondansetron: Concurrent use of these medications may result in increased ondansetron exposure..